arrow
Y

Yi-Tsung Lu

humboldt university of berlin
H指数:16
被引数:1,490

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study

恩福妥单抗联合帕博利珠单抗与铂类化疗相比对晚期尿路上皮癌患者生活质量的影响:EV-302研究患者报告结局的通俗语言摘要

2026-04-010
PRE
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study

恩诺单抗维多汀联合帕博利珠单抗对比化疗在先前未经治疗的局部晚期或转移性尿路上皮癌患者中的疗效(EV-302):一项开放标签、随机对照、III期研究的患者报告结局

2025-05-280
PRE
Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases
CANCER
IF5.1
2015-05-14103
OAAI
NanoVelcro Chip for CTC enumeration in prostate cancer patients
METHODS
IF4.3
2013-12-01122
OAAI
A Microfluidic Platform for Systems Pathology: Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens
2010-07-28101
OAAI